Paclitaxel in the Adjuvant Setting: Results so Far Are Inconclusive
- 作者Amy I. D'Orazio; I. Craig Henderson; George W. Sledge; Joyce O'Shaugnessy
- 卷第2卷
- 期第1期
- 印刷ISSN1526-8209
- 电子ISSN1938-0666
- 文件大小106.59KB
- 发表时间2001
- DOI10.1016/s1526-8209(11)70315-9
Critical Review of Current Treatment Strategies for Advanced Hormone Insensitive Breast CancerVan Poznak, Catherine; Seidman, Andrew D. · Cancer Investigation · 2002
Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical TrialCatherine Van Poznak; Andrew D. Seidman; Marcus M. Reidenberg; Mark M. Moasser; Nancy Sklarin; Kimberly Van Zee; Patrick Borgen; Marc Gollub; Doreen Bacotti; T-J Yao; Renny Bloch; Monica Ligueros; Martin Sonenberg; Larry Norton; Clifford Hudis · 2001
Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast CancerModi, Shanu; DiGiovanna, Michael P.; Lu, Zhao; Moskowitz, Chaya; Panageas, Katherine S.; Van Poznak, Catherine; Hudis, Clifford A.; Norton, Larry; Tan, Lee; Stern, David F.; Carter, Darryl; Seidman, Andrew D. · Cancer Investigation · 2005
Phase I study of intermittent high dose lapatinib alternating with capecitabine for HER2-positive breast cancer patients with central nervous system metastasesMorikawa, Aki; de Stanchina, Elisa; Pentsova, Elena; Kemeny, Margaret M; Li, Bob T.; Tang, Kendrick; Patil, Sujata; Fleisher, Martin; Van Poznak, Catherine; Norton, Larry; Seidman, Andrew D. · Clinical Cancer Research · 2019